$435 Million is the total value of Capital Advantage, Inc.'s 43 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 36.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IGHG | Buy | PS Interest Rate Hedged ETFetf | $45,695,000 | -1.2% | 632,638 | +1.7% | 10.51% | -5.2% |
| VIGI | Buy | Vanguard International Dividend ETFetf | $36,709,000 | -3.2% | 464,404 | +0.2% | 8.44% | -7.1% |
| VHT | Buy | Vanguard Health Care ETFetf | $27,250,000 | +4.2% | 107,124 | +1.0% | 6.27% | +0.0% |
| LQDH | Sell | iShares Interest Rate Hedged Corp Bd ETFetf | $24,883,000 | -2.7% | 266,043 | -0.9% | 5.72% | -6.6% |
| FLTR | New | VanEck IG Floating Rate ETFetf | $23,596,000 | – | 940,065 | +100.0% | 5.43% | – |
| SCHD | Sell | Schwab US Dividend Equity ETFetf | $22,878,000 | -2.8% | 289,996 | -0.5% | 5.26% | -6.7% |
| XLF | Sell | Financial Select Sector SPDRetf | $22,228,000 | -4.1% | 580,071 | -0.1% | 5.11% | -8.0% |
| VIG | Sell | Vanguard Dividend Appreciation ETFetf | $21,467,000 | -2.7% | 132,384 | -1.5% | 4.94% | -6.7% |
| VOE | Buy | Vanguard Mid Cap Value ETFetf | $19,563,000 | +0.2% | 130,708 | +0.5% | 4.50% | -3.8% |
| IJR | Buy | iShares Core S&P Small Cap ETFetf | $17,405,000 | -1.4% | 161,339 | +1.0% | 4.00% | -5.4% |
| XLP | Buy | Consumer Staples SPDR ETFetf | $16,728,000 | +0.2% | 220,428 | +0.3% | 3.85% | -3.8% |
| MGV | Buy | Vanguard Mega Cap Value ETFetf | $16,068,000 | +1.9% | 149,721 | +1.9% | 3.70% | -2.2% |
| VPL | Sell | Vanguard Pacific Index ETFetf | $15,308,000 | -3.8% | 206,732 | -0.1% | 3.52% | -7.7% |
| VGK | Buy | Vanguard FTSE Europe ETFetf | $13,608,000 | -2.1% | 218,503 | +5.9% | 3.13% | -6.0% |
| VYMI | Buy | Vanguard International High Dividend ETFetf | $13,473,000 | +6.1% | 199,244 | +9.3% | 3.10% | +1.8% |
| IEFA | Buy | iShares Core MSCI EAFE ETFetf | $12,579,000 | -5.4% | 180,971 | +0.2% | 2.89% | -9.2% |
| VXUS | Sell | Vanguard Total International Stock ETFetf | $11,750,000 | -5.5% | 196,689 | -0.1% | 2.70% | -9.3% |
| AAPL | Sell | Apple Incequities | $10,616,000 | +2.5% | 60,796 | -0.3% | 2.44% | -1.7% |
| VBR | Buy | Vanguard Small Cap Value Index ETFetf | $9,095,000 | +7.2% | 51,691 | +8.0% | 2.09% | +2.9% |
| SCHM | Buy | Schwab US Mid Cap ETFetf | $7,865,000 | +1.6% | 103,681 | +2.5% | 1.81% | -2.5% |
| MGC | Buy | Vanguard Mega Cap Blend ETFetf | $7,718,000 | +2.1% | 48,530 | +3.5% | 1.78% | -2.0% |
| ICSH | Sell | BlackRock Ultra Short Term Bond ETFetf | $6,065,000 | -3.5% | 120,928 | -3.1% | 1.40% | -7.3% |
| MSFT | Buy | Microsoft Corpequities | $4,883,000 | +3.5% | 15,839 | +1.6% | 1.12% | -0.7% |
| AMD | New | Advanced Micro Devicesequities | $3,087,000 | – | 28,233 | +100.0% | 0.71% | – |
| IWM | iShares Russell 2000 ETFetf | $3,065,000 | -1.2% | 14,930 | 0.0% | 0.70% | -5.2% | |
| IPAC | Sell | iShares Core MSCI Pacific ETFetf | $2,984,000 | -5.6% | 48,994 | -2.6% | 0.69% | -9.4% |
| EXTR | Extreme Networks Incequities | $2,200,000 | -11.7% | 180,143 | 0.0% | 0.51% | -15.2% | |
| CVX | Buy | Chevron Corpequities | $1,974,000 | +26.5% | 12,125 | +0.6% | 0.45% | +21.4% |
| SCHX | Buy | Schwab US Large Cap ETFetf | $1,726,000 | -1.5% | 32,046 | +99.0% | 0.40% | -5.5% |
| UBER | Uber Technologies Incequities | $1,313,000 | -7.1% | 36,807 | 0.0% | 0.30% | -10.9% | |
| PFE | Buy | Pfizer Incequities | $1,182,000 | -0.9% | 22,833 | +3.6% | 0.27% | -4.9% |
| XOM | Buy | Exxon Mobil Corpequities | $1,109,000 | +24.5% | 13,433 | +10.1% | 0.26% | +19.2% |
| MRK | Sell | Merck & Co Incequities | $1,052,000 | -4.8% | 12,823 | -5.4% | 0.24% | -8.7% |
| INTC | Sell | Intel Corpequities | $1,025,000 | -12.2% | 20,683 | -3.0% | 0.24% | -15.7% |
| CSCO | Sell | Cisco Systems Incequities | $981,000 | -11.3% | 17,600 | -5.0% | 0.23% | -14.7% |
| VUSB | Sell | Vanguard Ultra-Short Bond ETFetf | $981,000 | -2.1% | 19,865 | -1.1% | 0.23% | -5.8% |
| SCHW | New | Charles Schwab Corpequities | $870,000 | – | 10,316 | +100.0% | 0.20% | – |
| T | Buy | AT&T Incequities | $808,000 | +16.9% | 34,176 | +35.1% | 0.19% | +12.0% |
| VWO | Buy | Vanguard FTSE Emerging Markets ETFetf | $664,000 | -1.8% | 14,396 | +6.3% | 0.15% | -5.6% |
| VGSH | New | Vanguard Short-Term Treasury ETFetf | $650,000 | – | 10,972 | +100.0% | 0.15% | – |
| VZ | Buy | Verizon Communications Incequities | $641,000 | +2.1% | 12,575 | +7.0% | 0.15% | -2.0% |
| SCHA | New | Schwab US Small Cap ETFetf | $569,000 | – | 12,023 | +100.0% | 0.13% | – |
| CMCSA | New | Comcast Corp Class Aequities | $532,000 | – | 11,356 | +100.0% | 0.12% | – |
| PJTGQ | Exit | Project Group Incequities | $0 | – | -19,000 | -100.0% | 0.00% | – |
| GDSI | Exit | Global Digital Solutions Incequities | $0 | – | -40,000 | -100.0% | 0.00% | – |
| QGSI | Exit | QuantGate Systems Incequities | $0 | – | -10,000 | -100.0% | 0.00% | – |
| PRXTF | Exit | Pure Extracts Technologies Corpequities | $0 | – | -10,000 | -100.0% | 0.00% | – |
| HPNN | Exit | Hop-On Incequities | $0 | – | -1,700,000 | -100.0% | -0.00% | – |
| SHMP | Exit | NaturalShrimp Incequities | $0 | – | -30,000 | -100.0% | -0.00% | – |
| Exit | VSBLTY Groupe Technologies Corpequities | $0 | – | -15,000 | -100.0% | -0.00% | – | |
| SVRA | Exit | Savara Incequities | $0 | – | -14,658 | -100.0% | -0.01% | – |
| ATRS | Exit | Antares Pharma Incequities | $0 | – | -13,000 | -100.0% | -0.01% | – |
| CYDY | Exit | CytoDyn Incequities | $0 | – | -91,000 | -100.0% | -0.01% | – |
| MINT | Exit | PIMCO Enhanced Short Maturity ETFetf | $0 | – | -74,111 | -100.0% | -1.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp | 39 | Q3 2023 | 1.2% |
| Chevron Corp | 39 | Q3 2023 | 1.0% |
| Facebook Inc Class A | 39 | Q3 2023 | 1.3% |
| AT&T Inc | 39 | Q3 2023 | 0.6% |
| Pfizer Incorporated | 39 | Q3 2023 | 0.3% |
| Cisco Systems Inc | 39 | Q3 2023 | 0.3% |
| Verizon Communications Inc | 39 | Q3 2023 | 0.3% |
| iShares Russell 2000 ETF | 38 | Q2 2023 | 1.4% |
| Vanguard Dividend Appreciation ETF | 37 | Q3 2023 | 8.4% |
| Merck & Co Inc | 37 | Q2 2023 | 0.4% |
View Capital Advantage, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-23 |
| 13F-HR | 2023-10-30 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-24 |
| 13F-HR | 2022-10-31 |
| 13F-HR | 2022-07-21 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-01-21 |
| 13F-HR | 2021-10-07 |
View Capital Advantage, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.